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Abstract 
 
Background: Cell-derived plasma microparticles (<1.5 µm) originating from various 
cell types have the potential to regulate thrombogenesis and inflammatory responses. 
The aim of this study was to test the hypothesis that microparticles generated during 
hepatic surgery co-regulate post-operative pro-coagulant and pro-inflammatory events.  
Methods: In 30 patients undergoing liver resection, plasma microparticles were 
isolated, quantitated and characterised as endothelial (CD31+, CD41-), platelet 
(CD41+) or leukocyte (CD11b+) origin by flow cytometry and their pro-coagulant and 
pro-inflammatory activity was measured by immunoassays. 
Results: During liver resection the total numbers of microparticles increased with 
significantly more Annexin V-positive, endothelial and platelet-derived microparticles 
following extended hepatectomy compared to standard and minor liver resections. After 
liver resection, microparticle tissue factor and pro-coagulant activity increased along 
with overall coagulation as assessed by thrombelastography. Levels of leukocyte-
derived microparticles specifically increased in patients with systemic inflammation as 
assessed by C-reactive protein but are independent of the extent of liver resection.  
Conclusions: Endothelial and platelet derived microparticles are specifically elevated 
during liver resection, accompanied by increased pro-coagulant activity. Leukocyte-
derived microparticles are a potential marker for systemic inflammation. Plasma 
microparticles may represent a specific response to surgical stress and may be an 
important mechanism of postoperative coagulation and inflammation. 
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Introduction 
 
Initially described as “platelet dust” in 19671, platelet-derived microparticles (MP) and 
other circulating cell-derived MP have been recognized as important mediators of 
inflammation and coagulation. These MP are of potential relevance for extracellular cell 
signalling and have been shown to be important in different disease states2.  
Vascular and abdominal surgery provokes a local and systemic pro-inflammatory and 
pro-coagulant stimulus3, catalyzing an acute phase reaction for several days post-
intervention. Post-operative hypercoagulability may manifest itself as venous or arterial 
thrombotic events and is associated with significant morbidity, mortality and costs4. In 
addition to platelets, a variety of MP play a decisive role in coagulation5-6. In particular 
platelet-derived, endothelium-derived and leukocyte-derived MP contribute to local and 
systemic coagulation7 by expressing a variety of surface markers such as 
phosphatidylserine, CD61, P-selectin and factor X, interact with glycoprotein ligand-1 to 
localize tissue factor, 2-integrins or ICAM-18-9. In vivo, MP influence endothelial 
dysfunction in patients with myocardial infarction and metabolic syndrome10-11, whilst 
recent data suggest a clear association of circulating MP with cardio-metabolic risk 
factors, in particular dyslipidemia, highlighting effects on endothelial integrity12. 
Increasing evidence suggests MP may be relevant in many settings of inflammation 
and organ injury and possibly represent a biomarker for various diseases, such as 
septic shock-induced disseminated intravascular coagulation13 and atherosclerosis14. 
Not only the number of MP is changed in the setting of disease, but also their function, 
as a recent study has shown that MP from patients with Crohn’s disease significantly 
alter endothelial and vascular function15. Recent literature reveals a significant impact 
of the release of microparticles and alterations in coagulation in trauma patients and in 
patients undergoing cardiac or vascular surgery16-17. 
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The liver is the main organ regulating systemic inflammation and coagulation, however 
data regarding generation of MP in the context of liver disease is scarce. It has been 
reported that MP released from liver cells potentially modulate cirrhosis and cirrhotic 
vasculopathy18-20. In the context of liver transplantation, increased hepatocellular 
damage, platelet activation, as well as augmented levels of platelet MP were observed 
in the post-operative period in the patient group with elevated markers of ischemia and 
reperfusion injury21 and correlate with acute liver failure22. Furthermore, a recent study 
in a murine model of acute hepatic ischemia and reperfusion injury suggests specific 
roles for microparticle subsets in modulating the response to reperfusion injury23. 
Currently no data exist on how extensive liver surgery other than transplantation, with 
particular regard to extent of surgical intervention and hepatic inflow occlusion, affect 
MP generation and distribution. 
The aim of the current study therefore was to test the hypothesis that MP generated 
during hepatic surgery co-regulate post-operative pro-coagulant and pro-inflammatory 
events.  
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Materials and methods 
 
Study design and patient collection 
According to the guidelines for good clinical practice, the study protocol was approved 
by the institutional review board and cantonal ethics committee of Bern, Switzerland. All 
patients gave written informed consent prior to study inclusion. he study was conducted 
according to the principles expressed in the Declaration of Helsinki. Eligible patients 
were at least 18 years of age and underwent planned, non-emergency liver and 
pancreatic surgery. Thirty patients undergoing liver surgery and thirteen patients 
undergoing pancreatic surgery (as controls) were enrolled in the study. We 
hypothesised that patients undergoing pancreatic surgery undergo significant changes 
in the coagulation system compared to patients undergoing liver surgery. The liver 
surgery population comprised 13 women and 17 men, with an average age of 58 years 
(range 30-81). Indications for an operative intervention included surgery for metastasis 
(n=11, 37%), hepatocellular carcinoma (n=6, 20%), cholangiocellular carcinoma (n=4, 
13%) and surgery for benign liver disease (e.g. hepatic adenoma, n=9, 30%). 
Segmentectomy was performed in five patients (17%), left hemihepatectomy in three 
patients (10%), central resection in four patients (13%), right hemihepatectomy in ten 
patients (33%) and extended hemihepatectomy in eight patients. All patients received 
prophylactic doses of subcutaneous weight-adapted low molecular weight heparin peri-
operatively. No other anticoagulants were specifically used in the immediate pre- or 
post-operative period. 
 
Collection of blood samples for microparticle isolation 
Venous blood was collected from a central line at various time points into 
ethylenediaminetetraacetic acid (EDTA) anti-coagulated sterile syringes. Cells were 
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removed by centrifugation (15 minutes at 1500 g at 20 °C). Platelet poor plasma (PPP) 
was generated by renewed centrifugation (1 minute at 20000 g), samples aliquoted and 
stored at -80 °C until use.  
 
Isolation of microparticles  
All PPP samples of one patient were tested in the same experiment to avoid day-to-day 
variations of the flow cytometer. PPP samples were slowly defrosted for 45 minutes in 
ice water. After careful mixing, 250 μl of PPP was transferred into a clean Eppendorf 
tube. MP were concentrated in two spin-down steps (30 minutes at 20000g at 20 °C 
each) and finally re-suspended in 75 μl citrate/phosphate-buffered saline (PBS). 
 
Reagents 
All reagents and antibodies were diluted in a calcium chloride/PBS solution (CaCl2 
2.5 mmol/L, pH 7.4, 0.2 μm filtered). The optimal antibody concentration was 
determined by titration. The following reagents and antibodies were used: Annexin V-
Cy5-APC (Allophycocyanin, MBL international Corporation, detection of 
phosphatidylserine, 1:300), CD31-FITC (Fluorescein isothiocyanate, eBioscience, 
monoclonal mouse anti-human, 1:1000), CD41-PE (Phycoerythrin, Dako, monoclonal 
mouse anti-human, 1:200) and CD11b-PE (BD Biosciences, USA, monoclonal mouse 
anti-human, 1:100). Isotype controls used were IgG1-PE, IgG2a-PE and IgG1-FITC (all 
from DAKO). For the Annexin V-APC negative control, Annexin V-APC was diluted 
1:300 in citrate/PBS solution. Endothelial MP were defined as CD31+ (CD41-), platelet 
as CD41+ (showing weak CD31+) and leukocyte MP as CD11b+. 
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Flow cytometric analysis of microparticles 
All tests were performed with triple staining in duplicates. MP-suspensions were 
incubated with antibodies for 30 minutes at room temperature in the dark. The reaction 
was stopped by adding 900 μl citrate/PBS solution. Samples were analysed by BD LSR 
II flow cytometer and FlowJo Computer Software (Version 8.8.2 for Mac). Prior to 
measurement, the cytometer was subjected to a 30 minute wash process to minimise 
background noise. Forward and sideward scatter were set at logarithmic gain (Figure 
1A and B). The measurement time for each tube was set at 90 seconds. MP were 
identified by size <1.5 μm (size calibration using TetraSpeck microspheres 1.5 μm, 
Invitrogen, Figure 1A and B) and primarily gated for Annexin V-APC positive events. 
This population, identified as MP were stained for cell membrane markers to determine 
cellular origin (Figure 1C). Numbers were corrected for haemodilution.  
 
Multiplex analysis of microparticle-rich plasma 
A Bio-Plex human cytokine assay for simultaneous quantitation of nine cytokines (IL-
1ß, IL-6, IL-8, IL-10, IL-12, IL-13, IFN-γ and TNF-) was performed in MP-rich plasma 
samples according to the manufacturer’s instructions (Bio-Rad Laboratories, Hercules, 
CA). The tested parameters were measured by sandwich immunoassay using the 
Luminex fluorescent bead technology. Data analysis was done with Bio-Plex Manager 
version 4.0 software with five-parametric curve fitting (Bio-Rad Laboratories).  
 
Analysis of MP pro-coagulant activity and MP tissue factor activity 
To assess MP pro-coagulant activity and MP tissue factor activity in plasma, the 
commercial Zymuphen MP-activity immunoassay kits (Hyphen BioMed, France) were 
used. 
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For pro-coagulant activity, in brief, diluted platelet poor plasma samples were 
supplemented with calcium, Factor Xa and thrombin inhibitors and were introduced into 
microplate wells coated with streptavidin and biotinylated Annexin V. After an 
incubation and a washing step, the Factor Xa-Va mixture containing calcium was 
added, followed by addition of purified prothrombin. When present in the tested sample, 
on the surface of MP bind to Annexin V, subsequently allowing to Factor Xa-Va, in 
presence of calcium, to activate prothrombin to thrombin. The concentration of 
phospholipids represents the limiting factor. The phospholipid concentration and the 
amount of thrombin generation, which is measured via its specific activity on the 
thrombin substrate, directly correlate. Following stopping of the reaction with 2 % citric 
acid, the absorbance is measured at 405 nm. 
To assess MP exposing surface-bound tissue factor platelet poor plasma samples were 
added to microplate wells coated with a murine monoclonal antibody specific for the 
extracellular domain of human tissue factor. Tissue factor bearing MP present in the 
sample bound to the immobilized antibody following overnight incubation. After 
washing, factor VIIa and factor X were added. The complex of tissue factor together 
with FVIIa leads to activation of FX to FXa on the surface of anionic phospholipids on 
the MP surface. Surface tissue factor on the MP are the rate-limiting step. A yellow 
chromogen is produced following the addition of a specific substrate for FXa and the 
absorbance, which is directly proportional to amount of MP tissue factor, measured at 
405nm. 
 
Soluble complement C3a and C5b-9 ELISA in platelet poor plasma samples 
Soluble C3a and Cb5-9 levels were measured in PPP samples according to the 
manufacturer’s guidelines (both Quidel, San Diego, CA, USA). In brief, samples and 
controls were incubated in a specific microtiter plate coated with a murine monoclonal 
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antibody specific for a neo-epitope on human C3a. Following washing, a horseradish 
peroxidase-conjugated polyclonal antibody to the C3a region of C3 and a chromogenic 
substrate were added and colour intensity measured spectrophotometrically at 450nm. 
For measurement of C5b-9, a similar procedure was followed, using a murine 
monoclonal antibody that binds specifically to the C9 ring of sC5b-9, followed by an 
HRP-conjugated polyclonal anti-C5b-9 antibody and chromogen and colour intensity 
was measured at 450nm. 
 
Thrombelastography (TEG) Analysis 
For TEG analysis, 1 ml of patient blood was added to a tube containing 1 % celite. The 
solution was mixed by inversion and 360 µl were transferred into a disposable cup and 
inserted into a computer-controlled TEG® 5000 Thrombelastograph® Hemostasis 
Analyzer (Haemonetics Corporation, Braintree, MA, US). The following TEG variables 
were measured for each sample: reaction time (r-time; normal range, 5.5-7.5 min), clot 
formation time (k-time; normal range, 1.5-3.5 min), angle (normal range, 54-74°), and 
maximum amplitude (MA; normal range, 55-68 mm). All normal ranges refer to celite-
activated whole blood samples. The time needed to form a stable clot (TMA, time to 
maximal amplitude), the G-parameter as a measure of clot firmness and E-parameter 
as a measure of the elasticity constant were measured and expressed as dyn/cm2. Clot 
lysis parameters including A30 and A60 (point measurements that look at TEG tracing 
amplitude; lysis at 30 and 60 minutes after maximum amplitude) and Ly60 (percent 
lysis 60 minutes after maximum amplitude) were also evaluated. A TEG coagulation 
index (CI) describing the subject’s overall coagulation was derived from the r-time, k-
time, MA, and angle. Positive values outside this range indicate that the sample is 
hypercoagulable; negative values that the sample is hypocoagulable. 
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Statistical Analysis 
Concentration and type of MP were related the extent of liver resection over time. The 
impact of hepatic inflow occlusion was assessed in a post hoc analysis. A p-value of 
<0.05 was considered as the level of significance. Data were compared by use of one-
way-analysis of variance (ANOVA) or, where appropriate, by use of two-way repeated-
measures ANOVA, with correction for multiple testing. Data collection, data 
management, and data analysis were performed with the statistical package SPSS 
Version 15 (Chicago, IL). As this was primarily an observational study, no prior formal 
power analysis was performed. Instead, group numbers were chosen according to 
experience from previous work to take into account the expected range of inter-
individual variation of MP numbers.  
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Results 
 
Determination of microparticle (MP) numbers 
MP derived from platelet poor plasma were stained with Annexin V and cell surface 
markers and analysed by flow cytometry (see materials and methods and 
representative dot blot in Figure 1).  
Absolute MP numbers, defined as an Annexin V positive population in a log-log setting 
by flow cytometry increased both in the minor and standard resection population (n=22) 
as well as in the patients with extended liver resection (n=8) during the operation, 
decreasing by post-operative days one and three (Figure 2 A). As compared to patients 
undergoing minor and standard hepatic resection, the increase in total Annexin V 
positive MP numbers was significant in patients undergoing extended liver resection 
and did not recover down to baseline values up to day three (Figure 2 A). Endothelial 
cell derived CD31+ but not leukocyte derived MP numbers were significantly elevated 
in patients undergoing extended liver resection compared to patients undergoing minor 
and standard resection (Figure 2 B, C). Patients undergoing liver resection frequently 
undergo temporary inflow occlusion in order to control haemorrhage.  In 10 patients 
that underwent inflow occlusion the fraction of platelet derived CD41+ MP was 
selectively elevated to 72.3±11% compared to 56.7±17% at baseline (Figure 2 D). 
There is no significant association of pre- or intraoperative microparticles with surgical 
site infection. Baseline values reveal a significant association between the frequency of 
endothelial derived CD31 positive microparticles and the presence of malignant versus 
benign disease (69% (SD 16%) vs. 58% (CD3)).  
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Plasma/microparticle cytokines are increased in the immediate post-operative period 
MP containing platelet poor plasma from patients were analysed for cytokine levels 
(Figure 3). Unlike systemic cytokine levels these are likely in part MP-associated. Of 
the parameters tested, levels of IL-1ß, IL-6, IL-10 changed significantly during the 
course of the operation and in the immediate post-operative period. As compared to 
baseline values, levels of IL-1ß significantly increased at the immediate post-resection 
time point (p=0.0001) and remained significantly elevated as compared to baseline 
(p=0.042). IL-6 values continually increased from the immediate post-resection time 
point up to post-operative day one (p=0.003 and p=0.006 as compared to baseline), 
decreasing to non-significant levels thereafter (not shown). IL-10 values particularly 
increased significantly in the immediate post-operative phase (p=0.009), returning close 
to baseline thereafter, however, with a few outliers observed. The other cytokines 
measured (IL-8, IL-12, IL-13, IFN-γ or TNF-) did not show significant changes in the 
course of the operation or early post-operative period as compared to baseline (values 
not shown).  
 
C-reactive protein levels correlate with microparticle numbers 
Patients were stratified according to CRP levels arbitrarily below or above 100 mg/l. 
CRP levels at postoperative day 2 inversely correlated with numbers of circulating 
CD31+ (CD41-) MP (p=0.006) (Figure 4A). Conversely, CRP directly correlated with 
leukocyte-derived MP (p=0.039) (Figure 4B). Although to a lesser extent, platelet-
derived, CD41-positive MP were detected in circulation in the CRP “high” as compared 
to the “low” group, although this was not statistically significant (Figure 4C). 
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Microparticle tissue factor activity and total microparticle pro-coagulant activity are 
increased during surgery whilst complement C3a initially decreases in major liver 
surgery 
In the whole study population, MP tissue factor activity was significantly increased 
during the operative period as compared to baseline (p=0.017 at 2 hours, p=0.004 at 4 
hours and p=0.006 at 6 hours, Figure 5A). Interestingly, MP tissue factor activity 
dropped during the first day post-surgery and rapidly thereafter, with values in the post-
operative period no longer significantly different as compared to baseline. Activation of 
complement, measured as soluble C5b-9 in plasma samples by ELISA, was highly 
variable but not significantly different between the time points and particularly as 
compared to baseline (p>0.05, Figure 5B). Another soluble complement activation 
product, the anaphylatoxin C3a, did also not show any significant changes throughout 
the intra- and immediate post-operative period, when grouping all patients together 
(p>0.05, Figure 5C). However, if the patients were divided into minor and standard 
versus major liver resection, the patients in the major liver resection group revealed 
decreased levels of circulating C3a within the first few hours of the operation (p=0.015 
at 4 hours and p=0.012 at 6 hours, Figure 5D). Overall, MP total pro-coagulant activity 
in all patients increased during surgery and up to day one post-operatively as 
compared to baseline (Figure 5E), recovering thereafter. 
 
Overall coagulation parallels elevation of pro-coagulant MP activity 
In order to compare MP pro-coagulant activity with overall coagulation, a TEG analysis 
was performed pre-operatively, during the operation and at day one post-operatively. 
The TEG coagulation index, which describes overall coagulation, increased during the 
operation as compared to baseline (p=0.003, Figure 6 A), with values dropping in the 
immediate post-operative period and at post-operative day one to return to baseline, 
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paralleling the increase in pro-coagulant MP activity already measured by 
immunoactivity assay. 
In order to assess the influence of intraoperative manipulation of organs in the upper 
abdominal tract per se on TEG values, pancreatic resections were used as controls. 
TEG readings increased from a normal, negative value at baseline to a positive value 
at two hours after incision, indicating a slight trend towards hypercoagulability in this 
early intra-operative time point (Figure 6 B). Coagulation index was significantly 
different after hepatic resection compared to pancreatic resection. Significant 
differences were found after 2 hours, 4 hours and the elevation at 2h and decrease at 4 
hours post incision was higher post hepatic (Figure 6 B). Ly60, indicating clot lysis 60 
minutes after maximum amplitude (which represents ultimate strength of the clot and is 
a measure of platelet function) showed a bimodal distribution and was only elevated 
after pancreatic resection (Figure 6 C).  
 
Standard laboratory tests 
Laboratory values from patients undergoing standard and extended hepatectomy were 
measured at various time points. White and red blood cell concentration such as 
leukocyte count, haemoglobin concentration and thrombocyte count did not change 
significantly over time. Similarly measures of liver injury such as bilirubin, alanine amino 
transferase and coagulation assessed by prothrombin time did not change significantly 
over time (data not shown).  
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Discussion 
 
Aim of the current study was to evaluate the impact of liver resection on the source and 
activity of circulating microparticles (MP). The main findings of the study reveal that MP 
are elevated during liver resection. In particular, absolute MP numbers and more 
specifically endothelial- and platelet-derived MP numbers were significantly elevated in 
extended as compared to standard and minor liver resections. These data suggest that 
overall MP count may appear to correlate with the extent of hepatic tissue resection. 
Furthermore, this study reveals that the subset of platelet-derived MP is specifically 
elevated after hepatic ischemia due to inflow occlusion. This is in line with previous 
data where, in the situation of liver transplantation, an increase in levels of platelet MP 
were observed post-operatively in the patient group with elevated markers of ischemia 
and reperfusion injury21. A large part of this increase, particularly in platelet-derived MP, 
is most likely due to increased shedding from activated platelets22-24. To which extent a 
reduced clearance may have contributed to this increase is not clear and remains to be 
investigated. Furthermore, our findings corroborate results from a very recent study in a 
murine model of hepatic ischemia and reperfusion injury, which revealed an elevation 
of circulating MP – in particular platelet and neutrophil MP23. Not only this current work, 
but also very recent studies currently raise the question whether the observed 
alterations in MP numbers in hepatic disease directly reflect the pathophysiological 
insult to the liver or compensatory responses, in acute (such as in this study) or also 
chronic liver injury25. Interestingly we found a significant association with the frequency 
of endothelial-derived microparticles and the presence of malignant versus benign 
disease (69% (SD 16%) vs. 58% (CD3)). These results support the hypothesis that 
microparticles may mediate angiogenic factors as shown in patients undergoing 
surgery for biliopancreatic malignancies26, but requires further investigations. 
Formatted: English (United Kingdom)
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Pro-inflammatory profile post-liver surgery 
Operative interventions represent a major pro-inflammatory and pro-coagulant stimulus. 
This is confirmed in the current study, revealing an augmented cytokine response in the 
early post-operative phase. Time point and elevation of the cytokine response 
corresponds in part to the elevated number (as detected by flow cytometry) as well as 
increased total pro-coagulant activity (as detected by immunoactivity) of the MP 
population. These data suggest that also in man, as previously shown in mice and in 
vitro 2, 27-28, MP may boast a role as carriers for cytokines, delivering pro- as well as 
potentially anti-inflammatory signals to target sites.  
 
Thrombogenicity in the post-operative period  
In this study we describe a transient state of hypercoagulability in the early 
postoperative phase of major uneventful abdominal surgery that was detected by MP 
coagulation index and thrombelastography but was not obvious in standard coagulation 
assays such as prothrombin time as assessed by INR. This hypercoagulability appears 
to be predominantly caused by a relevant elevation of platelet activity, which is in line 
with the finding that in addition to platelets, platelet-derived MP also play a decisive role 
in coagulation29, 6. Post-operative hypercoagulability may therefore more accurately be 
reflected by platelet activity and activation products i.e. platelet-derived MP than more 
commonly used coagulation assays. Whether this translates to and correlates with an 
increased risk for peri-operative thrombo-embolic events was presently not specifically 
addressed. However, up until release from hospital none of the patients presented with 
clinically manifest thrombo-embolic events. 
 
In the study population total MP tissue factor activity, as measured by immunoactivity 
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assay, was increased in the immediate post-operative period. Interestingly, not only 
platelet-derived, but also leukocyte-derived MP importantly contribute to coagulation7 in 
vivo by binding to activated platelets to localize tissue factor to and induce fibrin 
generation at the site of injury9. In the current study, leukocyte-derived MP numbers 
were also increased in the early post-operative phase, possibly indicating a role for 
leukocyte-MP in regulation of early post-operative coagulation events. Equally 
endothelial-derived MP interact with monocytic cells in vitro to stimulate tissue factor-
mediated pro-coagulant activity, in part dependent on the interaction of intercellular 
adhesion molecule-1 on the MP and 2-integrins26.  
 
Soluble complement activation products C3a and C5b-9 were measured by ELISA in 
platelet poor plasma samples. Although differences were noted in plasma levels of 
C5b-9, these were not significant between groups (standard vs. extended liver 
resection) potentially because of the surgically induced reduction of total liver 
parenchyma, which typically synthesizes complement. The drop in leukocyte-derived 
MP may be explained by sequestered ectosomes (MP) derived from human 
polymorphonuclear neutrophils that activate and bind complement, possibly leading to 
clearance from the circulation much like the removal of circulating immune 
complexes30.  
 
Study limitations 
One limitation of the study is the non-homogenous patient population undergoing liver 
surgery ranging from benign to malignant diseases. Previous studies have shown 
alterations in MP tissue factor activity samples in cancer patients31-32. The differences 
in MP pro-inflammatory and pro-coagulant activity in this study were not dependent on 
the initial condition with which the patient presented. The extent of the operation and 
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whether or not the intervention necessitated a phase of hepatic ischemia and 
reperfusion more importantly impacted on MP numbers and distribution. A lack of 
association of MP number with a defined clinical outcome parameter is another 
limitation. Nevertheless, the incidence of post-operative complications such as surgical 
site infections, biliary fistula or post-operative hepatic insufficiency is well below 10% 
and consequently patient number would need to be increased at least ten fold in order 
to determine good correlations. The current study does however show an association 
between MP numbers and CRP – a marker typically accepted as a good predictor of 
post-operative complications and outcome33. Because the field is still novel, analysis of 
MP, including the method of detection, determination of size and accurate gating in flow 
cytometry as well as quantification are currently not yet standardized34-35. And whilst 
flow cytometry currently largely remains the standard of MP analysis, the method in 
itself may inherently miss a possibly relevant number and population of MP not 
amenable to flow cytometric analysis (due to too small size). No significant association 
of microparticle count with surgical site infection was observed. However, this study 
was neither powered nor designed to address this question. 
 
In summary MP are significantly elevated and ratios of platelet-, endothelial and 
leukocyte-derived MP are altered during major liver resection. These released and 
measurable circulating MP seem to represent a specific response to surgical stress and 
potentially exhibit specific thrombogenic and pro-inflammatory properties. 
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Legends to figures  
 
Figure 1 
Flow cytometric analysis of circulating microparticles (MP) from platelet poor 
plasma. 
Microspheres of 1.5 µM (black arrow) were used as size references to gate the MP 
population (defined as <1.5 µM) and regulate acquisition (A). Events falling in the MP 
gate (B) were gated for positivity for Annexin V. This population, identified as MP, was 
stained for cell membrane markers to determine cellular origin (C). Dot blots depict 
representative examples of actual blots used for subsequent analyses.  
 
Figure 2 
Relative number of total microparticles as measured by flow cytometry. 
MP were assessed in patients undergoing liver resection for different conditions. Total 
number of circulating MP were elevated in patients undergoing extended liver resection 
compared to standard resection (A). Endothelial cell derived MP but not leukocyte 
derived MP were significantly elevated after extended (n=8) versus standard/minor 
(n=22) liver resection (B, C). Interestingly, platelet derived CD41-positive MP were 
significantly elevated at postoperative day one in patients in which temporary inflow 
occlusion compared to patients without inflow occlusion (D).  
 
Figure 3  
Measurement of cytokines in patient plasma during the peri-operative period. 
Cytokines with pro-inflammatory properties (IL-1ß, IL-6) or anti-inflammatory properties 
(IL-10) were measured by ELISA from the patients’ plasma (platelet poor plasma, MP-
containing) before operation (baseline), after hepatic resection and at postoperative 
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day one. The levels of IL1ß were significantly elevated post resection (p=0.0001) and at 
postoperative day one (p=0.042) compared to baseline (A). Levels of IL-6 were 
significantly elevated post resection (p=0.003) and at postoperative day one (p=0.006) 
compared to baseline (B). Levels of IL-10 were only significantly elevated post 
resection (p=0.009) but not at postoperative day one compared to baseline (C) 
 
Figure 4 
Percentages of the individual microparticle subpopulations as measured by flow 
cytometry. 
Representation of CD31-positive (A), CD11b-positive (B) and CD41-positive (C) 
microparticle (MP) populations, were compared according to C-reactive protein (CRP) 
values above or below 100mg/l. Significant inverse correlation of numbers of circulating 
CD31-positive MP with CRP (p=0.006). Significant direct correlation of leukocyte-
derived MP with CRP (p=0.039). No significant correlation of platelet-derived, CD41-
positive MP with CRP. 
 
Figure 5 
Measurement of microparticle-associated tissue factor, plasma levels of 
complement activation products and microparticle pro-coagulant activity. 
Activation of tissue factor (A) and complement, measured by plasma levels of C5b-9 
(B) and complement C3a in all patients (C) and in patients after extended liver 
resection (D) as well as microparticle (MP) pro-coagulant activity (E) were measured by 
immunoactivity rsp. enzyme-linked immunosorbent assay (ELISA). Significant increase 
of tissue factor activation was observed during the operation but not at later time points. 
Decrease of complement C3a activation was observed at 4 and 6 hours but not at the 
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other time points. Significant increase in MP pro-coagulant activity was noted during 
surgery and up to day one post-operatively as compared to baseline (p=0.005, E).  
 
Figure 6 
Thrombelastography measurements of patient blood samples. 
Thrombelastography (TEG) was performed in order to correlate microparticle (MP) pro-
coagulant activity with overall coagulation parameters and to compare between hepatic 
and pancreatic operations. The TEG coagulation index represents a composite score of 
various parameters assessed during TEG. Significant increase in coagulation index 
during the operative procedure was observed as compared to baseline (p=0.003), with 
values dropping in the immediate post-operative period and at post-operative day 1 
(p=0.040, A). In order to compare for the intra-operative manipulation of abdominal 
organs, pancreatic resections were used as controls. Coagulation index was 
significantly more variable after hepatic resection as compared to pancreatic resection 
at early time points (B). Ly60, a marker for fibrinolysis, revealed significant responses in 
patients undergoing pancreatic resection but not following liver resection (C). 
 
